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Abstract
The polysaccharide capsule of Streptococcus pneumoniae defines over ninety serotypes, which differ in their carriage
prevalence and invasiveness for poorly understood reasons. Recently, an inverse correlation between carriage prevalence
and oligosaccharide structure of a given capsule has been described. Our previous work suggested a link between serotype
and growth in vitro. Here we investigate whether capsule production interferes with growth in vitro and whether this
predicts carriage prevalence in vivo. Eighty-one capsule switch mutants were constructed representing nine different
serotypes, five of low (4, 7F, 14, 15, 18C) and four of high carriage prevalence (6B, 9V, 19F, 23F). Growth (length of lag phase,
maximum optical density) of wildtype strains, nontypeable mutants and capsule switch mutants was studied in nutrient-
restricted Lacks medium (MLM) and in rich undefined brain heart infusion broth supplemented with 5% foetal calf serum
(BHI+FCS). In MLM growth phenotype depended on, and was transferred with, capsule operon type. Colonization efficiency
of mouse nasopharynx also depended on, and was transferred with, capsule operon type. Capsule production interfered
with growth, which correlated inversely with serotype-specific carriage prevalence. Serotypes with better growth and higher
carriage prevalence produced thicker capsules (by electron microscopy, FITC-dextran exclusion assays and HPLC) than
serotypes with delayed growth and low carriage prevalence. However, expression of cpsA, the first capsule gene, (by
quantitative RT-PCR) correlated inversely with capsule thickness. Energy spent for capsule production (incorporation of H3-
glucose) relative to amount of capsule produced was higher for serotypes with low carriage prevalence. Experiments in
BHI+FCS showed overall better bacterial growth and more capsule production than growth in MLM and differences
between serotypes were no longer apparent. Production of polysaccharide capsule in S. pneumoniae interferes with growth
in nutrient-limiting conditions probably by competition for energy against the central metabolism. Serotype-specific
nasopharyngeal carriage prevalence in vivo is predicted by the growth phenotype.
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Introduction
Streptococcus pneumoniae is a major pathogen causing several serious
human diseases including pneumonia, meningitis and sepsis as well
as being a common cause of otitis media. The bacteria are usually
surrounded by one of at least 92 known varieties of polysaccharide
capsule [1,2] which acts as the most important virulence factor by
protecting the bacteria from destruction by host phagocytes [3,4].
On the basis of the reaction between the polysaccharide capsule and
specific antibody, S. pneumoniae is classified by serotype. Whilst some
serotypes have a tendency to colonize the nasopharynx more often
asymptomatically, others are found to be carried less frequently but
are associated with invasive and mucosal disease [5–7]. The reasons
for this difference between serotypes have not been clearly
established.
Our previous work suggested a link between colonization
prevalence in vivo, capsule type and growth in vitro [8–10].
Weinberger et al. [7] have suggested that increased carriage
prevalence is associated with heavier encapsulation for protection
from neutrophil-mediated killing. This group also found an inverse
correlation between carriage prevalence and the predicted
metabolic burden of capsule type, based on the number of
carbons and the number of high-energy bonds required to
generate one polysaccharide repeat unit.
Little is known about the nutritional environment which is
encountered by S. pneumoniae in the nasopharynx but we propose
that when comparing phenotypes of different serotypes in vitro it
may be important to consider their behaviour in a relatively
nutritionally poor environment. This might more closely reflect
the nasopharynx than very rich media commonly used for in vitro
culture. For example, albumin concentration in the fluid layer
covering the epithelium in the lower respiratory tract is
approximately 10-fold lower than serum albumin concentration
[11]. Here, we investigated whether the burden of capsule
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production manifested itself as a delay or reduction in growth of
the bacteria under conditions of restricted nutrition as might be
experienced in the nasopharynx. The use of 81 different capsule
switch mutants allowed us to exclude any effects of the genetic
background. Our results suggest that, indeed, capsules of low
prevalence serotypes do delay and reduce growth and that this
effect is transferrable with the capsule operon. We found a
significant correlation between carriage prevalence of serotypes
and their growth phenotype. We also found a relationship between
amount of capsule produced and serotype: High prevalence
serotypes making more capsule than low prevalence serotypes in
nutrient-restricted conditions.
Results
Capsule types exhibit distinct growth patterns which are
transferred with capsule genes
Strains representing the low carriage serotypes 4, 7F, 14, 15,
and 18C and the high carriage prevalence capsule types 6B, 9V,
19F, and 23F were used. Growth over 20 hours was monitored for
wildtype strains, non-encapsulated mutants in which the capsule
operon was replaced by the Janus cassette and capsule switch
mutants using a nutrient-limited modified Lacks medium (MLM)
and the rich non-defined BHI+FCS medium. Experiments using
capsule switch pairs of two 7F and one 6B strain demonstrated
that serotype 7F and 6B exhibit different growth patterns, which
could be transferred with the capsule operon (Figure 1 and Figure
S1). In MLM, the 7F wildtype barely grew but loss of the 7F
capsule operon allowed enhanced growth and this was only slightly
reduced by acquisition of the 6B capsule (Figure 1A). In contrast,
the wildtype 6B strain grew well in the MLM but loss of capsule or
replacement with the 7F capsule reduced and delayed growth
(Figure 1B). However, such growth differences were not apparent
in the rich BHI+FCS medium (Figure 1C).
In order to extend this observation to more serotypes, but
exclude an effect of the chromosomal background, growth patterns
were studied for capsule switch mutants of two 7F strains, an 18C
strain and a 19F strain in the same 6B background. Growth was
measured quantitatively by measuring the length of the lag phase
(until reaching an OD450 nm of 0.3) and the maximum OD450 nm.
The results showed that serotype 6B wildtype strain had a shorter
lag phase and grew to a higher OD450 nm than wildtype strains of
serotypes 7F, 18C and 19F in MLM (Figure 2A). Following
replacement of the 6B capsule with 7F, 18C or 19F capsules,
growth of capsule switch mutants in MLM was reduced relative to
the 6B wildtype. Growth was enhanced for capsule switch mutants
of serotypes 7F and 18C strains relative to their donor strains and
growth was similar for the 19F capsule switch mutant and the
donor strain (Figure 2B). This effect was not seen in BHI+FCS
medium where growth of all wildtype strains was similar (with the
exception of the serotype 18C strain which had a prolonged lag
phase in this medium) (Figure 2C). In BHI+FCS, the capsule
switch mutants grew to a lower OD than the wildtype 6B strain
with the exception of the recipient of the 18C capsule which grew
as well as the 6B wildtype (Figure 2D).
In order to determine the effect of additional serotypes, the
growth of 10 strains in which the capsule operon had been
replaced by the Janus cassette was compared with that of their 10
parent strains (Table S1) and with that of 81 capsule switch
mutants in which a new capsule operon (serotypes 4, 6B, 7F, 9V,
14, 15, 18C, 19F, 23F) was inserted in place of the Janus cassette
(Table S2). Change in growth due to the capsule type was
calculated as the difference in time to reach an OD450 nm of 0.3
between the non-encapsulated Janus mutant and the strain of the
same genetic background but with a new capsule. The average
values of these changes in growth in MLM due to capsules of
different serotypes are shown in Figure 3A. The greatest growth
delays in MLM were due to capsules of serotypes 15, 7F, 4 and
18C and, to a lesser extent, serotype 14. Capsules of serotypes 19F,
23F, 9V and 6B seemed to cause less or no delay in growth. The
delay in growth due to capsule was less in BHI+FCS medium and
differed less between the serotypes (Figure 3B).
Capsule type related growth patterns correlate with
carriage prevalence
The average values of changes in growth due to different
capsule types (see above and Figure 3) were plotted against the
percentage carriage prevalence of serotype determined by the
epidemiological study of Brueggemann et al. [5]. Figure 4A shows
that there is an inverse correlation between delay of growth due to
capsule type and percentage carriage prevalence (p = 0.0114), with
serogroup 9 as somewhat of an outlier. The delay in growth due to
capsule was less in BHI+FCS medium and differed less between
the serotypes (data not shown). A significant inverse correlation
was also found when the growth delay was plotted against the
percentage carriage prevalence data of a Swiss population [6]
(p = 0.0387) and data from an international study [7] (p = 0.0379)
(Figure S2).
In a similar manner, the difference in maximum OD450 nm due
to the capsule type in MLM was plotted against percentage
carriage prevalence data obtained from the study of Brueggemann
et al. [5] and a significant a positive correlation was found
(p = 0.0114) (Figure 4B). Using the prevalence values of the Swiss
study [6] a significant correlation was also observed (p= 0.0361)
and using the prevalence values of Weinberger et al. [7] the same
trend was observed but narrowly missed being statistically
significant (p = 0.0511) (Figure S3).
Carriage efficiency depends on, and is transferred with,
capsule operon
Figure 5 shows the colonization efficiency of different wildtype
strains and mutants in the nasopharynx of mice over the course of
a week. By day 7 after inoculation, the wildtype serotype 6B strain
had established a higher level of colonization than the wildtype 7F
Author Summary
Streptococcus pneumoniae bacteria are responsible for
serious human infections including meningitis, pneumonia
and bacteraemia and are a common cause of otitis media
(ear infection) in children. However, they most often reside
harmlessly in the infant nasopharynx. An association has
long been observed between the type of polysaccharide
capsule surrounding the bacteria and harmless coloniza-
tion versus invasive disease. Here we suggest that capsule
types that are costly for the bacteria to make are produced
in lower quantities and their production limits the growth
of the bacteria in nutrient-restricted conditions. In contrast,
bacteria with capsules that require less energy can
produce more capsule and grow more successfully. This
may be an explanation for why S. pneumoniae with certain
capsule types can be effective long-term colonizers of the
nasopharynx while others need a richer nutritional
environment to flourish and so are most often associated
with invasive disease. This information may be of use when
considering which capsules types to target in future
vaccines.
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strain (p = 0.0017). However, in the mutant in which the 7F
capsule had been removed (208.41 Janus), colonization was
significantly greater than that of its parental serotype 7F strain
(p = 0.0008). In contrast, when the 6B capsule was replaced with a
7F capsule (mutant 106.66cps208.41) colonization decreased
significantly compared with that of the 6B parental strain
(p = 0.0063). For the serotype 6B strain, loss of the capsule
(resulting in 106.66 Janus mutant) was a disadvantage for
colonization (p = 0.0011).
Capsule types differ by their metabolic burden
As a measure of the relative metabolic burden of the capsule,
the fraction of 3H-labelled glucose taken up and detected in the
capsule was determined. Figure 6 shows the results for wildtype
strains and capsule switch mutants pooled by serotype and
normalized for colony forming units and thickness of capsule.
Strains with 7F and 18C capsules incorporated a higher
proportion of glucose into their capsules than the high colonization
prevalence serotypes 6B and 19F in the MLM (p= 0.0068) but in
the BHI+FCS medium there was no significant difference between
the serotypes (p = 0.9493).
There is a relationship between carriage prevalence and
capsule thickness in nutrient-restricted medium
Next, we investigated whether the relationship between capsule
type and growth pattern may be determined by the amount of
capsule produced since this poses a metabolic burden to the
bacterial cell. Capsule thickness was determined by electron
Figure 2. Growth curves of strain 106.66 (serotype 6B) after replacing 6B capsule operon with operons of different serotypes.
Growth of the wildtypes and nontypeable Janus mutant (A and C) and strain 106.66 with its capsule replaced by that of serotype 7F, 18C or 19F
strains (B and D) was measured in MLM (A and B) and BHI+FCS medium (C and D). In MLM, growth of 106.66 was reduced and delayed by acquisition
of other capsules. The effect was less for 19F than 7F or 18C reflecting the growth pattern of the wildtype donors. Graphs are representative of three
independent experiments.
doi:10.1371/journal.ppat.1002574.g002
Figure 1. Growth patterns of strain 208.41 of serotype 7F and strain 106.66 of serotype 6B and their capsule switch mutants. A) Loss
of 7F capsule greatly increases growth and acquisition of a 6B capsule has no effect on lag phase compared to the nontypeable Janus mutant in
MLM. Reacquisition of the 7F capsule reduces growth to that of the wildtype 7F strain. B) Loss of 6B capsule reduces maximum OD450nm and slightly
increases lag phase in MLM. Acquisition of a 7F capsule further enhances these effects. Reacquisition of the 6B capsule led to a lag phase between
that of the wildtype 6B strain and the Janus mutant. C) In BHI+FCS medium there is little difference in lag phase between the strains or maximum
OD450 nm between the wildtype strains. Graphs are representative of three independent experiments.
doi:10.1371/journal.ppat.1002574.g001
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microscopy (EM), FITC-dextran exclusion assay and quantitative
HPLC analysis of cell bound capsular polysaccharides in wildtype
strains of serotypes 7F (two strains), 18C, 6B and 19F and their six
capsule switch mutants (6B background with the two different 7F
capsules, 18C or 19F capsule and both 7F backgrounds with the
6B capsule). Examples of the EM images are shown in Figure 7
and for FITC-dextran assay in Figure 8 for a 7F serotype and a 6B
serotype.
By EM, it could be seen that in BHI+FCS medium strains
208.41 (serotype 7F) (Figure 7A) and 106.66 (serotype 6B)
(Figure 7B) expressed similar amounts of capsule. In MLM thicker
capsule can be distinguished for 106.66 (6B) (Figure 7D) than
208.41 (7F) (Figure 7C). Also by FITC-dextran assay, in BHI+FCS
medium strains 208.41 (Figure 8A) and 106.66 (Figure 8B)
expressed similar amounts of capsule. In MLM strain 106.66 (6B)
(Figure 8D) bacteria are bigger than strain 208.41 (Figure 8C).
For quantitative analysis, data was pooled for wildtypes strains
and capsule switch mutants of the same serotype as shown in
Figures 7E, 8E and 9. Comparisons were made between the low
carriage prevalence serotypes 7F and 18C and the high prevalence
serotypes 6B and 19F. Comparing capsule thickness in the two
media, for the 7F/18C group it was clear that the amount of
capsule was much reduced in the nutrient-restricted MLM
compared with BHI+FCS (p,0.0001) when determined either
by EM (Figure 7E) or FITC-dextran exclusion assay (Figure 8E)
and the same trend was seen by HPLC (p= 0.0763) (Figure 9). For
the 6B/19F group by FITC-dextran assay there was also more
capsule in BHI+FCS than MLM (p,0.0001) (Figure 8E) but by
EM (Figure 7E) and HPLC (Figure 9) the difference was not
significant (p = 0.0664 and p= 0.2877 respectively) indicating that
the nutrient-restricted medium has a less dramatic effect on
reduction of capsule thickness in the high prevalence serotypes 6B
and 19F. Comparing capsule thickness between the serotypes
within the same medium, in the nutrient-restricted MLM there
was significantly more capsule in the 6B/19F group whether
measured by EM (Figure 7E) or FITC-dextran assay (Figure 8E)
(p,0.0001) or by HPLC (Figure 9) (p = 0.0144). However, in
BHI+FCS medium capsule thickness was greater in the 7F/18C
group when measured by EM (Figure 7E) (p,0.0001) but greater
in the 6B/19F group when measured by FITC-dextran assay
Figure 3. Influence of capsule serotype on length of lag phase of growth in MLM (A) and BHI+FCS (B). Change in growth due to the
capsule type was calculated as the difference in time to reach an OD450 nm of 0.3 between the non-encapsulated Janus mutant and the strain of the
same genetic background but with a new capsule. The average values for each serotype are plotted; error bars represent one standard error. (For
serogroup 15 n=3, for 7F n = 10, for 4 n= 2, for 18C n= 12, for 14 n = 9, for 19F n= 11, for 23F n= 12, for 9V n= 9, for 6B n= 5). The greatest delay of
growth in MLM was caused by capsules of serotypes 15, 7F, 4 and 18C, and to a lesser extent 14.
doi:10.1371/journal.ppat.1002574.g003
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(Figure 8E) (p,0.0001) and almost equivalent when measured by
HPLC (Figure 9) (p = 0.9766) which may mean that in this rich
medium capsule thickness is similar for the different serotypes.
cpsA gene expression is lower in a nutritionally limiting
environment especially in serotypes with high carriage
prevalence
To address whether the differences observed in amount of
capsule were regulated by transcription of the capsule operon,
expression of the first gene, cpsA, was measured by real-time RT-
PCR and normalized against 16S rRNA gene expression for the
same strains as described in the capsule thickness experiments
above. Figure 10 shows that after pooling data for wildtype and
capsule switch mutants of the same serotype, for all serotypes
tested cpsA expression was greater in the BHI+FCS medium than
in the MLM (for 6B/19F p,0.0001, for 7F/18C p= 0.0375). In
MLM cpsA expression was lower for the 6B/19F serotypes than the
7F/18C (p= 0.0016). There was no significant difference between
the 7F and 18C versus the 6B and 19F in the BHI+FCS
(p = 0.8669). The reduction in cpsA expression when growing in
the MLM as compared to BHI+FCS was particularly marked for
the high carriage prevalence 6B and 19F serotypes (p,0.0001)
and to a lesser extent for the low carriage prevalence 7F and 18C
serotypes (p = 0.0375). Therefore, expression levels of the cpsA
gene agreed with capsule thickness in terms of being higher in the
rich BHI+FCS medium as compared to the MLM. However, in
MLM where differences between high and low carriage strains
were most apparent, the high carriage prevalence serotypes 6B
and 19F downregulated cpsA expression more than the low
prevalence serotypes 7F and 18C although capsule thickness was
higher in the high carriage prevalence strains than in the low
carriage prevalence strains.
Discussion
Although it has long been observed that some capsule serotypes
of S. pneumoniae are most commonly isolated from the nasopharynx
while others are predominantly found in normally sterile sites in
patients with invasive disease [5–7], the reason for this difference
has remained unclear. The role of the capsule is thought to be to
protect the bacteria from phagocytosis following invasion [3,4] and
in the nasopharynx to repel mucus and so aid colonization [12]. It
seems that the capsule type either enables a pneumococcus to
reside for a long time in the nasopharynx (high colonization
prevalence serotype) or causes it to be cleared quickly from the
nasopharynx necessitating invasion for its survival (low coloniza-
tion prevalence serotype). We speculate that this is because high
colonization prevalence serotypes can thrive in the nasopharynx
where as low colonization serotypes can only survive after invading
and reaching a nutritionally richer environment. Weinberger et al.
[7] have suggested that polysaccharide capsule serotypes differ in
terms of the metabolic demand placed on the bacteria for their
synthesis. They described an inverse correlation between the
number of carbons and high energy bonds and colonization
prevalence. Here we aimed to answer the question of whether
serotypes predicted to have a low metabolic demand for their
synthesis have high colonization prevalence because they have a
growth advantage. Therefore, we compared growth phenotype of
different serotypes and found that capsules predicted to be a low
metabolic burden do have a growth advantage in terms of a short
lag phase and a higher maximum optical density. These
experiments were performed in a modified version of Lacks
medium which we cannot be sure is an accurate representation of
the nutrient conditions in the nasopharynx but rather we assume is
closer to the nasopharyngeal conditions than rich media such as
brain heart infusion broth or Todd Hewitt broth enriched with
yeast extract often used to culture S. pneumoniae. Our version of the
medium is limited in amino acids and peptides compared with the
original Lacks medium in an attempt to mimic the nasopharyngeal
environment which albumin concentration measurements predict
to be more protein restricted than serum [11].
The growth advantage of having a capsule predicted to be of
low metabolic burden correlated with ability to colonize the
nasopharynx in a mouse model although a limitation of the in vivo
study was that it was restricted to serotype 7F and 6B wildtype
strains and their mutants. In addition, colonization was only
monitored during the first week after colonization while
colonization in the human nasopharynx occurs over a much
longer period. A further limitation is that we have not determined
whether differences in adherence to the epithelial cells play a role
in the serotype-specific difference in colonization efficiency along
with difference in growth.
Figure 4. Relationship between growth pattern and carriage
prevalence of serotype. A) For each serotype, the delay of growth
due to the capsule was plotted against percentage carriage prevalence
data obtained from a previous study [5] and an inverse correlation was
found, p = 0.0114. B) For each serotype, the difference in maximum
OD450 nm due to the capsule was plotted against percentage carriage
prevalence data [5] and a positive correlation was found, p = 0.0114.
doi:10.1371/journal.ppat.1002574.g004
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Also, adding experimental evidence to the prediction made by
Weinberger we saw that in the nutrient-restricted medium more
energy was required to synthesize the capsules of the low
colonization prevalence serotypes than the high colonization
prevalence serotypes. In addition, we found that in the nutrient-
restricted medium, serotypes with high colonization prevalence
were able to make thicker capsules than the low colonization
prevalence serotypes, as determined by electron microscopy,
FITC-dextran exclusion assay and HPLC. This seems compatible
with the idea that these capsules are less metabolically demanding
for the bacteria and so more can be made. A thicker capsule could
give these bacteria an advantage in resisting phagocytosis and
clearance by mucus in the nasopharynx. Interestingly, the
observation that high colonization serotypes make more capsule
was not reflected in expression of the first gene of the capsule
operon, cpsA, which in fact was slightly greater in the low
colonization serotypes. This is in agreement with our previous
study [10] which found an inverse correlation in BHI medium
between cpsA expression and colonization prevalence. This raises
the possibility that there is post-transcriptional control of capsule
expression. A limitation of the current study is that we have not yet
determined the mechanism of post-transcriptional control but the
role of tyrosine phosphorylation of the product of cpsD, on capsular
polysaccharide synthesis has already been described [13,14]. CpsC
and cpsD may regulate amount of capsule by affecting chain length
of the polysaccharide polymers [13,14]. The relationship between
CpsD phosphorylation and amount of capsule produced appears
to be affected by the genetic background of the bacteria suggesting
that a factor outside the capsule operon is also important in the
control of capsule synthesis [14]. In this study, although we
describe a relationship between capsule type and capsule thickness
we do not exclude that there is also control of capsule expression
by factors outside of the capsule operon.
However, cpsA expression was affected by the nutrient
availability in the medium: In the nutrient rich (BHI+FCS)
medium there was more cpsA expression and more capsule
production than in the nutrient-restricted (MEM) medium
suggesting that regulation of capsule expression at the level of
transcription also occurs.
In conclusion, in a nutrient-restricted environment, which
might reflect the environment in the nasopharynx, serotypes that
have a capsule which is not metabolically demanding to synthesize
may be able to grow well and sooner and make a thicker capsule
than serotypes with a metabolically demanding capsule. This
regulation may be, to a large extent, by a post-transcriptional
Figure 6. Metabolic burden of capsule was determined by
incorporation of 3H-labelled glucose into the capsule. The
fraction of labelled glucose taken up which was detected in the capsule
was determined for wildtype strains and capsule switch mutants and
the data pooled by serotype and normalized for colony forming units
and thickness of capsule. Strains with 7F and 18C capsules incorporated
a higher proportion of glucose into their capsules than the high
colonization prevalence serotypes 6B and 19F in the MLM (p= 0.0068)
but in the BHI+FCS medium there was no significant difference
between the serotypes (p = 0.9493).
doi:10.1371/journal.ppat.1002574.g006
Figure 5. Relationship between capsule type and carriage efficiency in a mouse model. Ability of wildtype strains and mutants to colonize
the nasopharynx of female MF1 mice was determined by quantification of colony forming units (CFU) per mg nasopharyngeal tissue on the day of
inoculation and 1 and 7 days later. By day 7, the disadvantage of a 7F capsule, but not a 6B capsule, in colonization was apparent. Error bars represent
one standard error.
doi:10.1371/journal.ppat.1002574.g005
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mechanism and give them an advantage in nasopharyngeal
colonization. This may explain why some serotypes such as 6B,
19F, are 23F more often found colonizing the nasopharynx than
serotypes such as 7F, 15 and 18C.
Materials and Methods
Ethics statement
All mouse experiments were conducted following guidelines
from University of Liverpool ethical review and animal welfare
committee. The mouse experiments were carried out under the
authority of the UK Home Office Animals Scientific Procedures
Act 1986. UK Home Office project Licence number PPL 80/
2111, personal licence number PIL 70/13633, study approved by
University of Liverpool Animal Welfare and Ethics Committee.
Mouse strains
Outbred, female MF1 mice (Harlan, UK) at 8–12 weeks of age
were used to model pneumococcal nasopharyngeal carriage
[15,16].
Carriage model
Mice were mildly anaesthetized with 2.5% (v/v) Isofluorane
USP (Isocare) over oxygen (1.4–1.6 litres/min) and 10 ml sterile
PBS containing 16105 S. pneumoniae was equally distributed
between both nostrils. At predetermined times, groups of 5
animals were sacrificed by cervical dislocation and nasopharyngeal
tissue, was dissected [17], placed into 5 ml sterile PBS, weighed,
disrupted with an Ultra-Turrax T8 homogeniser (IKA) and
numbers of pneumococci determined by colony counting [18].
Bacterial strains
Clinical isolates of Streptococcus pneumoniae were selected from two
nationwide surveillance programs collecting nasopharyngeal and
invasive isolates [6,19]. Strains and mutants used for this study are
listed in Tables S1 and S2.
Construction of capsule switch mutants
For 10 wildtype clinical isolates the capsule operon was removed
and replaced with a Janus cassette, as described below, rendering
these strains non-typeable. These strains are listed in Table S1 and
represent 7 different serotypes and 8 different genetic back-
grounds. Capsule operons from other strains were introduced into
these non-typeable mutants to give capsule switch mutants as
described below. These mutants are listed in Table S2. In total, 81
different capsule switch mutants were used in this study
representing 10 different serotypes.
For the construction of capsule switch mutants the bicistronic
cassette Janus was used [20,21]. Primers used for mutant
construction are listed in Table S3. The Janus cassette in the
form of a PCR construct of dexB-Janus-aliA was kindly provided by
K. Trczinski, (Harvard School of Public Health, Boston, USA).
The allele rpsL str1, which was kindly provided by D. Morrison
(University of Illinois, Chicago, USA) was amplified with forward
primer DAM350 and reverse Primer DAM351 by using Fast Taq
DNA polymerase (Roche Molecular Biochemicals, Rotkreuz,
Switzerland) according to the manufacturer’s instructions. Ampli-
fication was performed by using the following cycling conditions:
primary denaturation for 5 min at 94uC, followed by 30 cycles
consisting of 94uC for 30 s, 50uC (annealing temperature) for 30 s
and 72uC for 2 min (extension time) and then the last cycle for
10 min at 72uC.
The Janus cassette was amplified with forward primer
dexBstart2 and reverse Primer aliAend2 by using the Expand
Long Template PCR system (LRPCR) (Roche Molecular
Biochemicals, Rotkreuz, Switzerland). Amplification was per-
formed by using the following cycling conditions: primary
denaturation for 2 min at 92uC, followed by 10 cycles consisting
of 92uC for 10 s, 65uC for 30 s, and 68uC for 17 min and then 20
cycles in which each extension cycle was prolonged by 20 s. PCR
products were purified with a QIAquick PCR purification kit
(QIAGEN, Basel, Switzerland). The dexB-Janus-aliA PCR product
was used to transform pneumococcal clinical isolates with selection
Figure 7. Electron microscopy showing polysaccharide cap-
sules for measuring capsule thickness. In BHI+FCS medium (A and
B) strains 208.41 (serotype 7F) (A) and 106.66 (serotype 6B) (B)
expressed similar amounts of capsule. In MLM (C and D) thicker capsule
can be distinguished for 106.66 (6B) (D) than 208.41 (7F) (C). * indicates
capsule. Bar = 500 nm. E) Capsule thickness (nm) in wildtypes and
capsule switch mutants in BHI+FCS (B+F) medium and in MLM. Capsules
were thicker in BHI+FCS than in MEM (p,0.0001) for all serotypes
except 6B. In MLM, the high prevalence serotypes 6B and 19F had
thicker capsules than the low prevalence serotypes 7F and 18C
(p,0.0001). (n per serotype and medium category = 25–118).
doi:10.1371/journal.ppat.1002574.g007
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for Kmr to make the unencapsulated strains, which were used as
recipients. Chromosomal DNA of the ‘‘capsule donor’’ clinical
isolates was used to transform the recipients with selection for Smr
to create capsule switch mutants. The structure of the cps locus and
surrounding regions of the capsule switch mutants were confirmed
by RLFP analysis of the following PCR products: 1430-1402 (dexB-
cps-aliA locus) digested with RsaI, TTM07-09 (pbp2x-dexB flanking
cps upstream region) and TTM08-10 (aliA-pbp1a flanking cps
downstream region) both digested with Tsp509I [21]. Restriction
patterns were compared with recipient and donor strain.
Figure 8. FITC-dextran exclusion assay. In BHI+FCS medium (A and B) strains 208.41 (serotype 7F) (A) and 106.66 (serotype 6B) (B) expressed
similar amounts of capsule. In MLM (C and D) strain 106.66 (6B) (D) bacteria are bigger than strain 208.41 (7F) (C). All pictures are to the same scale,
original magnification= 630 X. E) Mean area per bacterium (square pixels) was greater in BHI+FCS than in MEM (p,0.0001). In both media bacteria of
6B and 19F serotypes had thicker capsules than bacteria of 7F and 18C serotypes (p,0.0001). (n per serotype and medium category = 96–647).
doi:10.1371/journal.ppat.1002574.g008
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Transformation was performed as described previously [22]
using 1 mg of DNA consisting of the rpsL str1 DNA fragment, dexB-
Janus-aliA PCR product, or 2 mg of the chromosomal DNA of the
donor strain. Aliquots of the cultures were then spread onto CSBA
plates containing 300 mg/ml streptomycin or 500 mg/ml kanamy-
cin. The plates were incubated for 24 h prior to subculture of
single colonies on CSBA plates. After serotyping, successful
transformants were stored for further evaluation at 280uC using
Protect bacterial preservers (Technical Service consultants,
Heywood, UK).
Growth media and measurement of growth
Two media were used to study the growth behaviour of the
bacteria. To represent a rich nutritional environment, brain heart
infusion broth (BHI) (Becton Dickinson and Company, le Pont de
Claix, France) supplemented with 5% foetal calf serum (FCS)
(Biochrom KG, Berlin, Germany) was used. This is referred to in
the text as BHI+FCS medium. To represent a more nutritionally
limited environment a modified version of Lacks medium was used
[23]. The principal modification from the original medium is that
the amino acid and peptide components are at one quarter of the
concentration of the original medium. The components of
modified Lacks medium (MLM) are listed in Table S4.
Strains were streaked onto Columbia sheep blood agar (CSBA)
plates and incubated at 37uC in a 5% CO2-enriched atmosphere
overnight then subcultured in growth medium to OD600 0.5,
centrifuged at 3000 g for 5 min and resuspended in growth
medium. Growth was monitored in sterile flat-bottomed 96-well
microtitre plates (Nunclon Surface, Nunc, Denmark) based on the
method of Brewster [24]. In brief, 200 ml bacteria culture was
grown per well and OD450 nm measured every 30 minutes using a
VERSAmax microplate reader (Molecular Devices) over 20 hours.
The plate was shaken automatically for 5 seconds before each
reading. The problem of condensation affecting the readings was
avoided by pre-treating the lids of the 96-well plates with 3 ml
0.05% Triton X-100 in 20% ethanol and allowing them to air-dry
before use.
Colony forming unit (CFU) quantification
Serial dilutions of 100 ml liquid culture in phosphate buffered
saline (PBS) were plated out onto CSBA plates at least in
duplicates and incubated overnight at 37uC with 5% CO2
atmosphere. The next day CFUs were counted with an in house
automated colony counter (Brugger S. et al., unpublished data)
and the bacterial load was calculated.
Energy deposition into the capsule
Strains were grown overnight on Columbia blood sheep agar
(CSBA) plates at 37uC with 5% CO2 atmosphere. Several colonies
were inoculated into 10 ml of growth medium (BHI+FCS or
MLM). The next day, 100 ml of the overnight culture in BHI+FCS
was inoculated into 10 ml of fresh BHI+FCS medium and 100 ml
of the overnight culture in MLM was inoculated into 10 ml of
fresh MLM, both supplemented with 1 mCi D-glucose-3H(U)
(ARC, St. Louis, MO). The subcultures were grown to an optical
density (OD) at 600 nm wavelength between 0.4–0.5 representing
mid-log phase of growth. Bacteria were harvested by centrifuga-
tion at 40006 G for 10 minutes at 4uC and washed with 5 ml
phosphate buffered saline (PBS). After ultracentrifugation with
200006G for 30 minutes at 4uC the bacterial pellet was dissolved
in 5 ml double distilled water, buffer saturated phenol was added
to a final concentration of 1% and incubated overnight at room
temperature. The released capsular polysaccharides were separat-
ed from the cells and detritus by centrifugation with 200006G for
30 minutes at 4uC. The supernatant containing the capsular
polysaccharides was decanted and the cells resuspended in 5 ml of
double distilled water. Radioactivity was determined in the
collected cell and capsule fraction (see above). Therefore, 500 ml
of each fraction was mixed with 1500 ml Microscint 40 scintillation
liquid and counts per minute were measured averaging 3 minutes
per sample with a Tri-Carb liquid scintillation counter (Perkin
Elmer, Waltham, MA). A capsule/cell beta counts ratio was
calculated for each tested strain to compare the energy distribution
for capsule assembly and cellular metabolism.
Quantification of capsule production
High performance liquid chromatography: Isolation of poly-
saccharide capsule was done using a procedure adapted from
Figure 9. Quantification of capsule by HPLC. Cell bound capsular
polysaccharides were released from wildtype strains and capsule switch
mutants and after hydrolysis resulting in monosaccharides were
quantified by reverse phase HPLC. The data was pooled by serotype.
doi:10.1371/journal.ppat.1002574.g009
Figure 10. Relative cpsA expression. CpsA expression is displayed
as the value for each isolate relative to that of the isolate with the
lowest expression, after normalization using 16S RNA gene expression
in BHI+FCS (B+F) medium and in MLM.
doi:10.1371/journal.ppat.1002574.g010
S. pneumoniae Serotype Affects Growth
PLoS Pathogens | www.plospathogens.org 10 March 2012 | Volume 8 | Issue 3 | e1002574
previously described methods [25,26]. Bacteria were harvested by
centrifugation and washed twice with phosphate buffer saline
(PBS) and double distilled water. After ultracentrifugation at
20000 g for 30 minutes at 4uC the pellet was dissolved in a 1%
buffer-saturated phenol solution. This mixture was incubated
overnight at room temperature to release cell bound capsular
polysaccharides. The capsular polysaccharides were separated
from the cells by ultracentrifugation at 20000 g for 30 minutes at
4uC. Polysaccharides were precipitated by adding sodium acetate
and ethanol to a final concentration of 7.2% and 60%, respectively
and incubation for at least 30 minutes at 4uC. The polysaccharides
were collected by centrifugation at 20000 g for 30 minutes and
remaining nucleic acids and proteins were digested by the
sequential addition of 250 U of Benzonase nuclease (Merck,
Darmstadt, Germany) (4 hours incubation) and 40 ml of a 20 mg/
ml proteinase K solution (Roche, Mannheim, Germany) (incubat-
ed overnight). Resulting low-molecular weight contaminants were
removed by centrifugation in an Amicon Ultra 30 kDa cut off
membrane centrifugal filter unit (Millipore, Billerica, MA) at
4000 g for 10 minutes at 4uC. The retained polysaccharides were
dried with heat in speed vac vacuum centrifuge. After resolution,
extracted capsular polysaccharides were hydrolysed as described
previously (ZITAT Saddic/ANumula). After complete hydrolysis,
the dried hydrolysed polysaccharides (i.e. monosaccharides) were
labelled with anthranilic acid (Fluka, Buchs, Switzerland) to enable
fluorescence detection in HPLC separation. Labelling was
performed as described previously [27–29].
Chromatographic separation was adapted from a previously
described method [29] using an AS2000A autosampler (Merck
Hitachi, Darmstadt, Germany) with an injection volume of 20 ml
per sample. Separation of the monosaccharide was done with a
flow rate of 0.85 ml/min as follows: 6% solvent B isocratic for
35 minutes followed by a linear gradient from 6 to 12% solvent B
over 20 minutes. Subsequently, a ten minute wash with 100% B
and 100% A for 15 minutes followed before re-equilibrating the
system with 6% B for minutes. Total run time was 85 minutes with
data collection for 60 minutes. A Luna 5 mm, C18, 15064.6 mm
column (Phenomenex, Torrance, CA) was used for separation and
column temperature was maintained at 35uC using a L5025
column oven (Merck Hitachi).
Anthranilic acid labelled monosaccharides were detected by
fluorescence (F-1080 Fluorescence Detector, Merck Hitachi) at an
excitation of 360 nm and an emission of 425 nm. Peaks were
identified by comparison of retention times with monosaccharide
standards and re-running after spiking to verify increase in the
peak of interest. Standard curves were generated for monosac-
charides of interest in at least three independent experiments.
Amounts of monosaccharides per bacterial cells were calculated
using peak heights and/or areas taking into account dilution
factors, sample and injection volumes used and relating to counted
CFUs (see above).
Electronmicroscopy. Strains were grown as described above
and harvested by centrifugation after reaching mid-log phase OD.
Cryofixation was achieved by high-pressure freezing as described
before [30]. To prevent freezing artifacts, pellets were dissolved
1:1 in the corresponding growth medium supplemented with 20%
dextrane and 5% sucrose. Ruthenium red was used to enhance
capsule resolution [31]. Capsule size was calculated from EM
pictures as described by Hyams et al. [32] after blinding.
FITC-dextran exclusion. Capsule thickness was also
determined by measuring the zone of exclusion of FITC-dextran
based on the method of Gates et al. [33] using FITC-dextran of
2000 kDa (Sigma). Bacteria were cultured overnight in BHI+FCS
medium or MLM until OD600 nm= 0.3 then 200 ml subcultured
into 10 ml of fresh medium and cultured again until OD600 nm 0.3.
After centrifuging at 3000 g for 5 minutes the pellet was
resuspended in 500 ml of PBS. 10 ml bacterial suspension was
mixed with 2 ml FITC-dextran (10 mg/ml in water), pipetted onto
a microscope slide and a coverslip applied firmly. Each strain was
prepared twice on different days. The slides were viewed using a
Zeiss Axio Imager.M1 fluorescence microscope with a 1006
objective and photographed by a Zeiss AxioCam HRc camera.
The images were converted to greyscale and analyzed with
UTHSCSA ImageTool for Windows v3.0 (University of Texas
Health Science Center in San Antonio) software. A brightfield
image was also photographed for each fluorescent image recorded
in order to count the number of bacteria per chain. For each strain
the mean area of between 47 and 247 bacteria was determined
after blinding. SAS 9.2 for Windows (SAS Institute Inc., Cary,
NC, USA) was used for the statistical analysis.
Expression of the capsule operon
Bacteria were cultured overnight in BHI+FCS medium or
MLM until OD600 nm 0.3 then 200 ml subcultured into 10 ml of
fresh medium and cultured again until OD600 nm 0.3. After
addition of 20 ml RNAprotect (Qiagen), RNA was extracted and
expression of the first gene of the capsule operon, cpsA, was
determined by real-time RT-PCR as described previously [10].
Statistical analysis
Student’s t-test was used to calculate p values using the software
GraphPad Prism (Version 5, GraphPad Software, Inc.). This
software was also used to calculate linear regression. A value of
p#0.05, two-tailed, was considered significant.
Supporting Information
Figure S1 A second example of growth patterns of
strains of serotypes 7F and 6B and their capsule switch
mutants. A) Loss of 7F capsule greatly increases growth and
acquisition of a 6B capsule causes only slightly increase the lag
phase compared to the NT Janus mutant and enhances maximum
OD450 nm in MLM. B) Loss of 6B capsule reduces maximum
OD450 nm and slightly increases lag phase in MLM. Acquisition of
a 7F capsule further enhances these effects. C) In BHI+FCS
medium there is little difference in lag phase between the strains or
maximum OD450 nm between the wildtype strain. Graphs are
representative of three independent experiments.
(TIF)
Figure S2 Relationship between delay of growth in
MLM due to capsule and carriage prevalence of
serotype. For each serotype, the delay of growth due to the
capsule was plotted against percentage carriage prevalence data
obtained from A) a local study [6], B) Weinberger et al. [7]. In
both cases an inverse correlation was found which was statistically
significant with p= 0.0387 and p= 0.0379 respectively.
(TIF)
Figure S3 Relationship between difference in maximum
OD450 nm in MLM due to capsule and carriage preva-
lence of serotype. For each serotype, the difference in
maximum OD450 nm due to the capsule was plotted against
percentage carriage prevalence data obtained from A) a local study
[6], B) Weinberger et al. [7]. In both cases a positive correlation
was found which for A and was statistically significant (p = 0.0361)
and for C gave a p value of 0.0511.
(TIF)
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Table S1 Wildtype clinical isolates from which non-
typeable Janus mutants were constructed.
(PDF)
Table S2 Capsule switch mutants.
(PDF)
Table S3 Primers used in construction of capsule
switch mutants.
(PDF)
Table S4 Composition of modified Lacks medium
(MLM).
(PDF)
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